Drugs

Pharmacotherapy of Mood Disorders and Treatment Discontinuation
pp. 1657-1663(7)
Author: Lader, Malcolm

Antileukotrienes as Adjunctive Therapy in Acute Asthma
pp. 1665-1670(6)
Authors: Kuitert, Lieske M.E.; Watson, Danie

Pathophysiology and Management of Diabetic Gastropathy: A Guide for Endocrinologists
pp. 1671-1687(17)
Authors: Kuo, Paul; Rayner, Christopher K.; Jones, Karen L.; Horowitz, Michael

Current Management of Mantle Cell Lymphoma
pp. 1689-1702(14)
Authors: Weigert, Oliver; Unterhalt, Michael; Hiddemann, Wolfgang; Dreyling, Martin

Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease
pp. 1703-1723(21)
Authors: Veres, Gabor; Baldassano, Robert N.; Mamula, Petar

Rasagiline: A Review of its Use in the Management of Parkinson's Disease
pp. 1725-1747(23)
Authors: Oldfield, Vicki; Keating, Gillian M.; Perry, Caroline M.

Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen): A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris
pp. 1749-1765(17)
Authors: Fenton, Caroline; Wellington, Keri; Moen, Marit D.; Robinson, Dean M.

Aliskiren: A Review of its Use in the Management of Hypertension
pp. 1767-1792(26)
Authors: Frampton, James E.; Curran, Monique P.

Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer
pp. 1793-1799(7)
Author: Scott, Lesley J.

Bevacizumab in First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by David Miles
pp. 1800-1801(2)
Author: Miles, David

Bevacizumab in First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by Xavier Pivot
pp. 1800-1801(2)
Author: Pivot, Xavier